Published in Thromb Res on May 01, 2016
Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators. Am J Hematol (1998) 2.78
Oxidative autoactivation of latent collagenase by human neutrophils. Science (1985) 2.40
Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A (2006) 2.01
Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor. Blood (2011) 1.72
Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood (1988) 1.72
Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma. Thromb Haemost (1991) 1.53
Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J Biol Chem (1998) 1.46
Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res (1988) 1.43
Genotype analysis identifies the cause of the "royal disease". Science (2009) 1.43
Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest (2001) 1.40
Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood (2006) 1.39
Activation of human factor V by factor Xa and thrombin. Biochemistry (1990) 1.39
Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood (1991) 1.37
Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor. Circulation (2003) 1.32
Secreted forms of human neutrophil collagenase. J Biol Chem (1986) 1.31
Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J Biol Chem (2000) 1.29
Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J Biol Chem (1990) 1.26
Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice. J Thromb Haemost (2009) 1.20
TFPIbeta, a second product from the mouse tissue factor pathway inhibitor (TFPI) gene. Thromb Haemost (1999) 1.15
Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. Blood (1985) 1.13
Investigation of the factor VIII intron 22 repeated region (int22h) and the associated inversion junctions. Hum Mol Genet (1995) 1.13
Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A. Blood (2007) 1.11
TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes. Blood (2011) 1.10
Biology of tissue factor pathway inhibitor. Blood (2014) 1.01
Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro. Thromb Haemost (2000) 1.01
A bipartite autoinhibitory region within the B-domain suppresses function in factor V. J Biol Chem (2012) 1.01
Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation. Proc Natl Acad Sci U S A (2013) 1.01
Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth. Arterioscler Thromb Vasc Biol (2011) 0.99
Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor. Proc Natl Acad Sci U S A (1990) 0.98
Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia. Proc Natl Acad Sci U S A (2012) 0.97
Proteolysis of tissue factor pathway inhibitor (TFPI) by plasmin: effect on TFPI activity. Thromb Haemost (1998) 0.96
Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8. Biochem J (2002) 0.95
Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model. Blood (2012) 0.94
Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor. Blood (2015) 0.93
Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A. Blood Coagul Fibrinolysis (1995) 0.92
A novel degradation pathway of tissue factor pathway inhibitor: incorporation into fibrin clot and degradation by thrombin. Blood (1997) 0.91
Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ. J Thromb Haemost (2013) 0.90
Effect of leukocyte proteinases on tissue factor pathway inhibitor. Thromb Haemost (1992) 0.89
Tissue factor pathway inhibitor attenuates the progression of malignant pleural mesothelioma in nude mice. Am J Respir Cell Mol Biol (2011) 0.89
Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. J Thromb Haemost (2015) 0.86
Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S. Blood (2012) 0.85
Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol (2013) 0.84
Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus. Arterioscler Thromb Vasc Biol (2012) 0.83
Aptamer BAX 499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein. J Thromb Haemost (2013) 0.83
Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI). J Biol Chem (2013) 0.81
A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development. Blood (2015) 0.80
Thrombosis: Balancing act. Nature (2014) 0.77